NCT03562806

Brief Summary

MRI 3D UTE Hyper-Cones \& ZTE for PET/MR lung attenuation correction \& for lung diagnostic imaging

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

May 23, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 20, 2018

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2021

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

2.8 years

First QC Date

May 23, 2018

Last Update Submit

May 16, 2022

Conditions

Lung Diseases

Outcome Measures

Primary Outcomes (1)

  • Confirm that lung density map extraction is feasible through Hyper-Cones & ZTE scanning.

    Confirm that lung density map extraction is feasible through Hyper-Cones \& ZTE scanning.

    1 year

Study Arms (1)

PET/MR (single arm)

EXPERIMENTAL

PET and MR sequence acquisition on SIGNA PET/MR device

Diagnostic Test: PET/MR image acquisition

Interventions

PET/MR image acquisitionDIAGNOSTIC_TEST

Acquisition of PET and MR sequences on SIGNA PET/MR device.

PET/MR (single arm)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • informed consent and signature
  • clinical PET/CT planned and performed at Wagi site in Schlieren
  • male or female patients
  • from 18 to 80 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich, Department of Nuclear Medicine

Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

  • Martin Huellner, M.D.

    University Hospital, Zürich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2018

First Posted

June 20, 2018

Study Start

May 23, 2018

Primary Completion

March 9, 2021

Study Completion

March 9, 2021

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations

CH(1)